Pharmacognosy Research logo
Submit
Pharmacognosy ResearchACADEMIC PUBLISHING
Article

Banisterine Alleviates Morphine‑based Nephrotoxicity by Antioxidant Property: An In vivo Study

1, 2, 1, 1

  1. 1Department of Anatomical Sciences, Medical School, Kermanshah University of Medical Sciences, Kermanshah, IRAN.
  2. 2Department of Anatomical Sciences, Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, IRAN.

CORRESPONDENCE

Shiva Roshankhah

Department of Anatomical Sciences, Medical School, Kermanshah University of Medical Sciences, Kermanshah, IRAN.

roshankhah@yahoo.com

Volume 12, Issue 2 · pp. 137-142 · 2020 · DOI: 10.4103/pr.pr_97_19

ABSTRACT

Background: Banisterine (BAN) as an alkaloid agent has antioxidant properties. The morphine (MOR) with the character of free radical generation has an effective role on renal pathogenesis.Objectives: This investigation critically examines the effects of the BAN against MOR‑induced damage to the kidneys of rats.Materials and Methods: Sixty‑four male Wistar rats were randomly assorted into 8 groups (8 rats in each), including the saline (Sal), MOR, BAN (5, 10, 15 mg/kg) and MOR + BAN treatment groups. All experimental procedures were applied by intraperitoneal injection daily for 20 days. Whole investigated values consist of total animal weight, weight of kidney, morphological criteria of kidney, antioxidant capacity and serum nitrite oxide levels.Results: Intraperitoneally MOR application significantly increased the levels of renal Malondialdehyde (MDA), blood urea nitrogen (BUN), blood creatinine, and blood nitrite oxide and also reduced the glomerular number and tissue ferric reducing/antioxidant power (FRAP) level compared to the Sal control group (P < 0.05). Treatment of BAN and BAN + MOR in all doses significantly reduced the levels of BUN, MDA, creatinine, glomerular diameter, and nitrite oxide and also increased the glomerular number and tissue FRAP levels compared to the MOR group (P < 0.05).Conclusion: The findings support the idea that the BAN with its antioxidant nature can eliminate MOR renal toxicity.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Salahshoor, M. R., Jalili, C., Abdolmaleki, A., & Roshankhah, S. (2020). Banisterine Alleviates Morphine‑based Nephrotoxicity by Antioxidant Property: An In vivo Study. Pharmacognosy Research, 12(2), 137-142. https://doi.org/10.4103/pr.pr_97_19

    Copyright and licence

    © 2020 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0